| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1022806146 |
| P356 | DOI | 10.1186/CC5133 |
| P932 | PMC publication ID | 1794494 |
| P698 | PubMed publication ID | 17184516 |
| P5875 | ResearchGate publication ID | 6614976 |
| P2093 | author name string | Yoram Kluger | |
| Philip Iau | |||
| Rolf Rossaint | |||
| Sandro B Rizoli | |||
| Bruno Riou | |||
| Brian Warren | |||
| Kenneth D Boffard | |||
| NovoSeven Trauma Study Group | |||
| Michael Tillinger | |||
| P2860 | cites work | Epidemiology of trauma deaths: a reassessment | Q28235326 |
| Mortality by cause for eight regions of the world: Global Burden of Disease Study | Q29615121 | ||
| Massive transfusion and coagulopathy: pathophysiology and implications for clinical management | Q33360283 | ||
| Transfusion medicine service policies for recombinant factor VIIa administration | Q33362187 | ||
| Management of massive blood loss: a template guideline | Q34096593 | ||
| Massive transfusion exceeding 50 units of blood products in trauma patients | Q34778500 | ||
| Massive blood transfusion in the elective surgical setting. | Q34802880 | ||
| Updates in the management of severe coagulopathy in trauma patients | Q34982424 | ||
| Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review | Q35617174 | ||
| A clinical review of bleeding dilemmas in trauma | Q35661489 | ||
| Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding | Q35839531 | ||
| Delayed brain injury after head trauma: significance of coagulopathy | Q35905754 | ||
| Validity of composite end points in clinical trials | Q36067984 | ||
| A review of recombinant factor VII for refractory bleeding in nonhemophilic trauma patients. | Q36068186 | ||
| Therapeutic approaches in trauma-induced coagulopathy. | Q36123531 | ||
| Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery | Q36151476 | ||
| Blood transfusion rates in the care of acute trauma. | Q38478829 | ||
| Factor VIIa for correction of traumatic coagulopathy | Q45130198 | ||
| Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force | Q45882922 | ||
| Platelet activity of high-dose factor VIIa is independent of tissue factor | Q45884609 | ||
| Early coagulopathy predicts mortality in trauma | Q47766285 | ||
| Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion | Q47784098 | ||
| Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. | Q50758503 | ||
| Recombinant factor VIIa for life-threatening post-partum haemorrhage. | Q51236864 | ||
| Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis. | Q51240376 | ||
| Distribution of the probability of survival is a strategic issue for randomized trials in critically ill patients. | Q52058580 | ||
| Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy | Q71137317 | ||
| Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited | Q73434813 | ||
| Acute traumatic coagulopathy | Q73544166 | ||
| Damage control surgery | Q76379308 | ||
| A possible mechanism of action of activated factor VII independent of tissue factor | Q77568932 | ||
| The use of recombinant factor VIIa in severe postpartum hemorrhage | Q80344979 | ||
| Early and delayed myocardial infarction after abdominal aortic surgery | Q81685582 | ||
| Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery | Q81884136 | ||
| P433 | issue | 6 | |
| P921 | main subject | blood coagulation disease | Q890200 |
| P304 | page(s) | R178 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials | |
| P478 | volume | 10 |
| Q35621790 | Clotting factor deficiency in early trauma-associated coagulopathy |
| Q46439266 | Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion |
| Q38548197 | Damage Control and the Open Abdomen: Challenges for the Nonsurgical Intensivist |
| Q50603071 | Effect of recombinant activated factor VII in critical bleeding: clinical experience of a single center. |
| Q35788608 | Evaluation of recombinant factor VIIa treatment for massive hemorrhage in patients with multiple traumas |
| Q88687080 | Factor VIIa administration in traumatic brain injury: an AAST-MITC propensity score analysis |
| Q49247169 | Hemostasis and nanotechnology |
| Q38646788 | Investigation of the status quo of massive blood transfusion in China and a synopsis of the proposed guidelines for massive blood transfusion |
| Q33983293 | Prophylactic activated recombinant factor VII in liver resection and liver transplantation: systematic review and meta-analysis. |
| Q50528606 | Resuscitation and monitoring in gastrointestinal bleeding. |
| Q34017702 | Role of factor VII in correcting dilutional coagulopathy and reducing re-operations for bleeding following non-traumatic major gastrointestinal and abdominal surgery |
| Q35071654 | Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature |
| Q34507452 | Successful use of N-acetyl cysteine and activated recombinant factor VII in fulminant hepatic failure and massive bleeding secondary to dengue hemorrhagic fever |
| Q33842873 | The acute management of trauma hemorrhage: a systematic review of randomized controlled trials |
| Q48116419 | The confusion continues: results from an American Association for the Surgery of Trauma survey on massive transfusion practices among United States trauma centers. |
Search more.